Myelos Corporation

Myelos’ unique, patented technology has permitted the rapid development of the company’s lead compound, Prosaptide™ TX14(A), from pre-clinical studies into Phase 2 clinical trials. The breadth of the technology platform and the "blueprint" afforded by the success of Prosaptide™ TX14(A) have provided the foundation for the development of other future therapeutics for a variety of degenerative diseases.

Contact Details: 4940 Carroll Canyon Road Suite M San Diego, CA 92121 United States of America Tel: (619) 657-1040 Fax: (619) 657-1038 Email: WWW: www.myelos.com/

Loading...

Myelos Corporation Patents:
US Patent No.	Title
7135461	Retro-inverso peptides derived from interleukin-6
7115571	Retro-inverso peptides derived from interleukin-3
7109168	Retro-inverso peptides derived from leukemia inhibitory factor
6590074	Prosaposin receptor
6559124	Use of prosaposin and peptides obtained therefrom for treatment of neural degeneration
→View more Myelos Corporation patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 484 times since April 2007, the link to the organisation's website has been followed 121 times

Recent Search Terms used to find this page: www.myelos.com | www.myelos.com | Myelos Corporation | www.myelos.com | myelos corporation | myelos | myelos | myelos | myelos | myelos | .

Search for more companies in San Diego,

Search for more companies in CA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Myelos Corporation